Inappropriate medications for elderly patients.

The use of medications is common in elderly persons, and this population has the highest risk of medication-related problems. Elderly persons are more susceptible to the effects of various medications for a number of reasons. It is well known that polypharmacy is one of the most serious problems in caring for elderly persons; however, many of these patients continue to receive medications that have an increased risk of causing harm. In 1991, an important article was published about inappropriate medication use in the elderly population. This article raised awareness of the problem and presented explicit criteria for determining which medications were inappropriate for elderly patients residing in long-term care facilities. This list of drugs is still used for evaluating medications taken by elderly persons and for determining whether satisfactory prescribing practices are being used. We reviewed the medications described as inappropriate for elderly persons and searched the scientific literature to determine whether evidence exists to defend or refute the labeling of particular drugs. At times, evidence was difficult to find, and many of the original studies were dated. For most medications listed as inappropriate, we found evidence to support these designations.

[1]  R. Young.  Double-Blind Placebo Controlled Oral Analgesic Comparison of Butorphanol and Pentazocine in Patients with Moderate to Severe Post-Operative Pain , 1973 .

[2]  W. Schaffner,et al.  The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations. , 1983, Journal of gerontology.

[3]  S. Finkel,et al.  A Retrospective Chart Review of Antidepressant Use, Effectiveness, and Adverse Effects in Adults Age 70 and Older. , 1996, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[4]  I. Ringqvist,et al.  Propafenone versus disopyramide for treatment of chronic symptomatic ventricular arrhythmias. A multicenter study. , 2009, Acta medica Scandinavica.

[5]  Miller Jm,et al.  Relief of severe pain with acetaminophen in a new dose formulation versus propoxyphene hydrochloride 65 mg. and placebo: a comparative double-blind study. , 1975 .

[6]  S. Yusuf,et al.  Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study. , 2001, Journal of the American College of Cardiology.

[7]  P. Davies,et al.  SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.

[8]  D. Classen,et al.  Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. , 1997, JAMA.

[9]  B. Pollock,et al.  Antipsychotics in Older Patients , 1995 .

[10]  A. Levi,et al.  BLOOD AND PROTEIN LOSS VIA SMALL-INTESTINAL INFLAMMATION INDUCED BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS , 1987, The Lancet.

[11]  Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. , 1993 .

[12]  J. Avorn,et al.  Psychoactive medication use in intermediate-care facility residents. , 1988, JAMA.

[13]  J. Hurley,et al.  Trimethobenzamide HCI in the Treatment of Nausea and Vomiting Associated with Antineoplastic Chemotherapy , 1980, Journal of clinical pharmacology.

[14]  D. Smith.  New rules for prescribing psychotropics in nursing homes. , 1990, Geriatrics.

[15]  J. Crooks,et al.  Cardiotoxicity of amitriptyline. , 1972, Lancet.

[16]  P. Corey,et al.  Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .

[17]  M. Llorente,et al.  Use of Antipsychotic Drugs in Nursing Homes: Current Compliance with OBRA Regulations , 1998, Journal of the American Geriatrics Society.

[18]  J. Avorn,et al.  Use of Psychoactive Medication and the Quality of Care in Rest Homes , 1989 .

[19]  T. Sunderland,et al.  Newer Psychotropic Medication Use in Nursing Home Residents , 1998, Journal of the American Geriatrics Society.

[20]  P. Robson,et al.  Double-blind crossover trial of oral meptazinol, pentazocine and placebo in the treatment of pain in the elderly. , 1980, Postgraduate medical journal.

[21]  R. Barnes,et al.  Pharmacologic Treatment of Agitation Associated With Dementia , 1986, Journal of the American Geriatrics Society.

[22]  R. Peters,et al.  Cardiovascular collapse associated with disopyramide therapy. , 1981, Chest.

[23]  M. Houston,et al.  Nonsteroidal anti-inflammatory drugs and antihypertensives. , 1991, The American journal of medicine.

[24]  T. Smith,et al.  Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: significance to clinical syndromes and their treatment. , 2001, British journal of biomedical science.

[25]  B. Pollock,et al.  Behavioral Disturbances of Dementia , 1998, Journal of geriatric psychiatry and neurology.

[26]  M. Gheorghiade,et al.  WITHDRAWAL OF DIGOXIN FROM PATIENTS WITH CHRONIC HEART FAILURE TREATED WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS , 2010 .

[27]  S. Pond,et al.  Effect of phenytoin on meperidine clearance and normeperidine formation , 1981, Clinical pharmacology and therapeutics.

[28]  J. Avorn,et al.  Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. , 2001, The American journal of psychiatry.

[29]  John R Bloomfield,et al.  Effects of Fexofenadine, Diphenhydramine, and Alcohol on Driving Performance , 2000, Annals of Internal Medicine.

[30]  T. Strandberg,et al.  Inappropriate drug prescribing in home-dwelling, elderly patients: a population-based survey. , 2002, Archives of internal medicine.

[31]  P. Jatlow,et al.  Major adverse reactions during desipramine treatment: relationship to plasma drug concentrations, concomitant antipsychotic treatment, and patient characteristics. , 1982, Archives of general psychiatry.

[32]  G P Samsa,et al.  Adverse Drug Events In High Risk Older Outpatients , 1997, Journal of the American Geriatrics Society.

[33]  Miller Jm,et al.  Acetaminophen extra strength capsules versus propoxphene compound-65 versus placebo: a double-blind study of effectiveness and safety. , 1975 .

[34]  S. Schenker,et al.  The effect of parenchymal liver disease on the disposition and elimination of sedatives and analgesics. , 1975, The Medical clinics of North America.

[35]  U. Klotz,et al.  Psychotropic drug use, falls and hip fracture in the elderly , 2000, Aging.

[36]  W. Ray,et al.  Opioid analgesics and the risk of hip fracture in the elderly: codeine and propoxyphene. , 1992, Journal of gerontology.

[37]  M. Murray,et al.  Adverse effects of nonsteroidal anti-inflammatory drugs on renal function. , 1990, Annals of internal medicine.

[38]  V Starbuck,et al.  Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance. , 1997, Archives of internal medicine.

[39]  Atkin Pa,et al.  Medication-related adverse reactions and the elderly: a literature review. , 1995 .

[40]  H. Szeto,et al.  Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer. , 1977, Annals of internal medicine.

[41]  T. Tammisto,et al.  Comparison of the Analgesic Effects of Intravenous Nalbuphine and Pentazocine in Patients with Postoperative Pain , 1977 .

[42]  B. Uretsky,et al.  Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. , 1993, Journal of the American College of Cardiology.

[43]  G S Meyer,et al.  Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. , 2001, JAMA.

[44]  S. Kollias,et al.  Transient ischemic attacks after dipyridamole-aspirin therapy , 2000, Journal of Neurology.

[45]  J. Lieberman,et al.  Neuroleptic treatment of elderly patients. , 1995, Psychopharmacology bulletin.

[46]  Stephen B. Soumerai,et al.  Improving Drug-Therapy Decisions through Educational Outreach , 1983 .

[47]  L. Melton,et al.  Psychotropic drug use and the risk of hip fracture. , 1987, The New England journal of medicine.

[48]  M. Beers,et al.  Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. , 1997, Archives of internal medicine.

[49]  A. A. Taylor,et al.  Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design. , 1984, Circulation.

[50]  G. Singh,et al.  Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. , 1998, The American journal of medicine.

[51]  R. J. Hayes,et al.  United Kingdom Prospective Diabetes Study 24: A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients with Newly Diagnosed Type 2 Diabetes That Could Not Be Controlled with Diet Therapy , 1998, Annals of Internal Medicine.

[52]  M. Kendall,et al.  The effect of ageing on plasma pethidine concentration. , 1975, British journal of clinical pharmacology.

[53]  R J Glynn,et al.  Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. , 1994, JAMA.

[54]  W A Ray,et al.  Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. , 1991, Annals of internal medicine.

[55]  Mats Thorslund,et al.  The Appropriateness of Drug Use in an Older Nondemented and Demented Population , 2001, Journal of the American Geriatrics Society.

[56]  B. E. Adams,et al.  Heat stroke associated with medications having anticholinergic effects. , 1977, Minnesota medicine.

[57]  J. Bigger,et al.  Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review. , 1981, Archives of general psychiatry.

[58]  M. Closser.  Benzodiazepines and the elderly. A review of potential problems. , 1991, Journal of substance abuse treatment.

[59]  V. Mor,et al.  Inappropriate drug prescriptions for elderly residents of board and care facilities. , 1997, American journal of public health.

[60]  R. Kane,et al.  Evaluation of neuroleptic drug use by nursing home elderly under proposed Medicare and Medicaid regulations. , 1991, JAMA.

[61]  L. Tune,et al.  ASSOCIATION OF POSTOPERATIVE DELIRIUM WITH RAISED SERUM LEVELS OF ANTICHOLINERGIC DRUGS , 1981, The Lancet.

[62]  M. Feinberg.  The Problems of Anticholinergic Adverse Effects in Older Patients , 1993, Drugs & aging.

[63]  W. Forrest,et al.  Evaluating side effects of analgesics in a cooperative clinical study , 1968, Clinical pharmacology and therapeutics.

[64]  J. Avorn,et al.  Drug Use in the Nursing Home , 1996, Annals of Internal Medicine.

[65]  D A Bloch,et al.  Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use. , 1989, Gastroenterology.

[66]  P. Kwo,et al.  Nonsteroidal anti-inflammatory drug-induced enteropathy: case discussion and review of the literature. , 1995, Mayo Clinic proceedings.

[67]  T. Gibson.  Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl. , 1996, The American journal of medicine.

[68]  B. Schwartz.  Current concepts in ophthalmology: the glaucomas. , 1978, The New England journal of medicine.

[69]  J. Avorn,et al.  The ambiguous relation between aging and adverse drug reactions. , 1991, Annals of internal medicine.

[70]  S. Wallenstein,et al.  A comparison of the analgesic effects of profadol and morphine in patients with cancer , 1966, Clinical pharmacology and therapeutics.

[71]  J. Avorn,et al.  Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study. , 1995, The American journal of medicine.

[72]  J S Harmatz,et al.  Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly , 2012, Clinical pharmacokinetics.

[73]  S R Salem-Schatz,et al.  A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. , 1992, The New England journal of medicine.

[74]  J. Pain,et al.  Non-steroidal anti-inflammatory drugs and peptic ulcer perforation. , 1985, Gut.

[75]  Stewart Rb,et al.  Studies on the epidemiology of adverse drug reactions. VI. Utilization and interactions of prescription and nonprescription drugs in outpatients. , 1971 .

[76]  I. Russell,et al.  Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. , 1993, Arthritis and rheumatism.

[77]  Samson Hh.  QUALIFICATION AS CONSULTANT. , 1963 .

[78]  Y. Yazaki,et al.  Multiple strictures of the small intestine after long-term nonsteroidal anti-inflammatory drug therapy. , 1992, The American journal of gastroenterology.

[79]  M. Reidenberg,et al.  Serum Digoxin Concentration and Age * , 1980, Journal of the American Geriatrics Society.

[80]  F. Simons,et al.  Central nervous system effects of H1-receptor antagonists in the elderly. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[81]  D. Kennedy,et al.  Drug use in the United States in 1981. , 1984, JAMA.

[82]  W. Ray,et al.  Adverse drug reactions and the elderly. , 1990, Health affairs.

[83]  L. Rubenstein,et al.  Inappropriate medication use in community-residing older persons. , 1994, Archives of internal medicine.

[84]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[85]  H. Morgenstern,et al.  Inappropriate Medication Prescribing in Skilled-Nursing Facilities , 1992, Annals of Internal Medicine.

[86]  R. Nelson,et al.  A double-blind randomized placebo controlled gastroscopic study to compare the effects of indomethacin capsules and indomethacin suppositories on the gastric mucosa of human volunteers. , 1982, The Journal of rheumatology.

[87]  W. Ray,et al.  Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease. , 1993, Archives of internal medicine.

[88]  Hirschowitz Bi,et al.  Controversies in the detection and management of nonsteroidal antiinflammatory drug-induced side effects of the upper gastrointestinal tract. , 1989 .

[89]  J. Frölich,et al.  Prostaglandin endoperoxide synthetase isoenzymes: the clinical relevance of selective inhibition. , 1995, Annals of the rheumatic diseases.

[90]  J. Hasegawa,et al.  Disopyramide Decreases the Fasting Serum Glucose Level in Man , 1999, Cardiovascular Drugs and Therapy.

[91]  D W Bates,et al.  Incidence and preventability of adverse drug events in nursing homes. , 2000, The American journal of medicine.

[92]  L. Nolan,et al.  Prescribing for the Elderly Part I: Sensitivity of the Elderly to Adverse Drug Reactions * , 1988, Journal of the American Geriatrics Society.

[93]  B. Lown,et al.  Congestive heart failure caused by oral disopyramide. , 1980, The New England journal of medicine.

[94]  R. O. Day,et al.  The Problems and Pitfalls of NSAID Therapy in the Elderly (Part I) , 1991, Drugs & aging.

[95]  K. Beard.  Adverse Reactions as a Cause of Hospital Admission in the Aged , 1992, Drugs & aging.

[96]  D B Reuben,et al.  Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. , 1991, Archives of internal medicine.

[97]  W. Ray,et al.  Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. , 1991, Annals of internal medicine.

[98]  J. Knoben,et al.  "Handbook of clinical drug data". , 1983, Canadian Medical Association journal.

[99]  H. Diener,et al.  European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke 1 1 ESPS-2 Writing Committee , 1996, Journal of the Neurological Sciences.

[100]  J. Freeman.  Some Principles of Medication in Geriatrics * , 1974, Journal of the American Geriatrics Society.

[101]  J L Kelsey,et al.  Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. , 1991, The New England journal of medicine.

[102]  W. Taylor,et al.  Relief of pain by oral medications. A controlled evaluation of analgesic combinations. , 1974, JAMA.

[103]  T. Cooper,et al.  Relationship between age and tricyclic antidepressant plasma levels. , 1977, The American journal of psychiatry.

[104]  D. Frush,et al.  Sedation of children for emergency imaging. , 1997, Radiologic clinics of North America.

[105]  G. Heidrich,et al.  Central nervous system excitatory effects of meperidine in cancer patients , 1983, Annals of neurology.

[106]  M. Langman,et al.  Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. , 1985, British medical journal.

[107]  E. Sellers.  Clinical pharmacology and therapeutics of benzodiazepines. , 1978, Canadian Medical Association journal.

[108]  G. Rivolta,et al.  Analgesic activity of tramadol and pentazocine in postoperative pain. , 1998, International journal of clinical pharmacology research.

[109]  Rudolf Hoehn-Saric,et al.  Generalized anxiety disorder. , 1985, The Psychiatric clinics of North America.

[110]  C. Forbes.  Secondary stroke prevention with low-dose aspirin, sustained release dipyridamole alone and in combination. ESPS Investigators. European Stroke Prevention Study. , 1998, Thrombosis research.

[111]  H Jick,et al.  Drug-related deaths among medical inpatients. , 1977, JAMA.

[112]  J. Roder,et al.  Blockade of glutamate receptors and barbiturate anesthesia: increased sensitivity to pentobarbital-induced anesthesia despite reduced inhibition of AMPA receptors in GluR2 null mutant mice. , 1999, Anesthesiology.

[113]  D. Himmelstein,et al.  Inappropriate drug prescribing for the community-dwelling elderly. , 1994, JAMA.

[114]  William J. Jusko,et al.  Berichten , 2005, Pharmaceutisch weekblad.

[115]  H. Trenholm,et al.  Toxicity of ethanol barbiturate mixtures , 1969, The Journal of pharmacy and pharmacology.

[116]  B. Winblad,et al.  Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. , 1998, American journal of epidemiology.